Vaginal estrogen is one of the most useful menopause treatments many women have never been clearly offered. It can help with symptoms that are often private, embarrassing, or misdiagnosed: vaginal dryness, burning, irritation, painful sex, urinary urgency, recurrent UTI-like symptoms, and the feeling that tissue is thinner, more fragile, or less comfortable than it used to be.
In a video on her channel, Dr. Heather Hirsch, MD, MS, MSCP, Chief Medical Officer of Flourish, describes vaginal estrogen as having safety and efficacy that is “really unparalleled.” She also frames the goal in plain language: helping keep things “happy after and through the menopause transition.” That matters because many women are not looking for a complex hormone lecture. They are looking for relief, comfort, and a way to understand what is happening to their body.
Why this has a name: GSM
Clinicians often use the term genitourinary syndrome of menopause, or GSM. Dr. Hirsch explains in the video that the older term, vulvovaginal atrophy, was too narrow because menopause-related estrogen changes can affect more than the vagina.
The lower genitourinary tract includes the vulva, labia, clitoris, vagina, urethra, bladder, and surrounding tissues. These tissues have many estrogen receptors. When estrogen falls during perimenopause and menopause, the tissue can become thinner, less elastic, less lubricated, and more vulnerable to irritation or infection.
That is why GSM can feel like several different problems at once. It may look like a sex problem, a urinary problem, a dryness problem, or a recurrent infection problem, even when the underlying pattern is related to estrogen-responsive tissue.
What vaginal estrogen is for
Vaginal estrogen is a prescription treatment used locally in the vaginal and vulvar area. It is commonly discussed for genitourinary syndrome of menopause, often called GSM.
GSM can include:
Symptoms it may help
Vaginal estrogen is usually discussed for local symptoms
- Vaginal dryness.
- Burning, itching, or irritation.
- Pain with sex or insertion.
- Tearing, fragility, or bleeding after sex.
- Urinary urgency or frequency.
- Recurrent UTI-like symptoms.
- Discomfort with exams, tampons, or daily friction.
ACOG explains that lower estrogen around and after menopause can affect vaginal lubrication, elasticity, and thickness. The Menopause Society describes GSM as involving vulvar, vaginal, and urinary symptoms related to the menopause transition.
This is why vaginal estrogen should not be framed only as a sex medication. For some women, it is about walking, sitting, wiping, exercising, sleeping, urinating, having intimacy without fear, or avoiding the cycle of repeated urinary discomfort.
Dr. Hirsch also emphasizes that painful sex can affect libido because the brain is not going to seek out an activity that hurts. A woman may love her partner and still avoid intimacy because the tissue pain is real. Treating GSM is therefore not only about lubrication. It can be about safety, comfort, desire, self-esteem, and quality of life.
Why GSM can get worse over time
Hot flashes may improve for some women over time. GSM often behaves differently. In the video, Dr. Hirsch calls it chronic and progressive because the estrogen-responsive receptors in the lower genitourinary tract do not simply disappear.
That is why symptoms may start mildly during perimenopause and become more disruptive later. Dryness may become pain. Pain with sex may become avoidance. Recurrent urinary symptoms may become a repeated cycle of tests, antibiotics, and frustration.
If these symptoms are affecting your life, it is reasonable to ask for care before they become severe.
Why it is often misunderstood
Many women hear the word estrogen and immediately think of systemic HRT, breast cancer risk, blood clots, or old warnings from hormone therapy studies. That fear is understandable. It is also one reason vaginal estrogen is underused.
But vaginal estrogen is not the same as taking estrogen by mouth or using an estrogen patch for whole-body symptoms. Mayo Clinic explains that vaginal estrogen works at lower doses and limits overall estrogen exposure because less hormone reaches the bloodstream. ACOG says topical estrogen acts locally on tissues.
Dr. Hirsch also addresses one of the most confusing parts of this topic: product labeling. For years, low-dose vaginal estrogen products carried broad boxed-warning language that many menopause clinicians felt reflected systemic hormone therapy concerns more than the evidence for local vaginal treatment. That warning scared many patients away from a treatment that menopause specialists often view very differently.
In November 2025, the FDA initiated removal of broad “black box” warnings from menopausal hormone therapy products after reviewing the scientific literature. The agency specifically noted that questions had been raised for years about whether boxed warnings from Women’s Health Initiative findings were warranted for local vaginal estrogen-only products. The Menopause Society said it agreed with the FDA’s decision to remove the boxed warning on low-dose vaginal estrogen therapies used for genitourinary symptoms.
For many patients, the important distinction is this: low-dose vaginal estrogen is meant to treat local tissue. It does not require progesterone for uterine protection in the way systemic estrogen usually does for patients with a uterus. The FDA change is important because it reflects what menopause specialists had been saying for years: the old warning overgeneralized risks and made a local treatment seem more dangerous than the evidence supported.
What forms it can come in
Vaginal estrogen can come as a cream, tablet, insert, suppository, or ring. Dr. Hirsch’s video focuses on commercially available vaginal estrogen products and how they are commonly used.
The “best” form is not the same for every person. It depends on symptoms, comfort with application, cost, pharmacy access, preference, and medical history.
Ask:
- Do I need treatment inside the vagina, around the opening, or both?
- Would a cream, insert, tablet, or ring fit my life best?
- How often do I use it at the beginning?
- What is the maintenance schedule?
- How long should it take before I notice improvement?
Mayo Clinic notes that vaginal estrogen products appear to work similarly overall, so patients and clinicians can choose based on fit.
Consistency matters. Dr. Hirsch notes that some patients stop because the product is cumbersome, messy, or hard to turn into a habit. That is not a minor issue. The right product is not only the one that works on paper; it is the one you can actually use.
Why symptoms may return if treatment stops
GSM is often chronic because the tissue changes are related to ongoing low estrogen. Moisturizers and lubricants can help symptoms, but they do not always address the tissue changes in the same way. Vaginal estrogen often requires a maintenance plan after the initial treatment phase.
This is one reason women may feel frustrated. They try something for a few weeks, improve, stop, and then symptoms come back. That does not mean they failed. It may mean the plan needs maintenance, follow-up, or adjustment.
Common practical questions include:
Practical questions
The details patients actually wonder about
- Will this affect my partner?
- Can I use it before sex?
- Can I use it more than twice per week?
- Do I need blood estrogen levels checked?
- What if it helps dryness but not pain?
- What if I cannot tolerate the cream or applicator?
The answers depend on the product and your clinician’s instructions, but the larger point is that these are normal questions. You should not have to guess how to use a medication that is meant for such a sensitive part of your life.
When in-person care matters
Vaginal estrogen can be appropriate for many women, but some symptoms need in-person evaluation.
GSM is common, but not every vaginal or urinary symptom is GSM. A good plan should be clear about when virtual menopause care is not enough.
What about breast cancer history?
This question should be individualized. Some women with a breast cancer history may be told to start with non-hormonal options first and involve their oncology team before using vaginal estrogen.
Mayo Clinic notes that a cancer specialist can help decide whether low-dose vaginal estrogen might help. The Menopause Society also frames low-dose vaginal estrogen as a possible option in some patients with cancer history after non-hormonal options and shared decision-making.
At Flourish, this is handled as a medical history and safety conversation, not as a blanket yes or no.
The same principle applies to gynecologic cancer history. Do not assume the answer is always no, and do not start without a clinician who understands your cancer history. The safest conversation is individualized and, when appropriate, coordinated with oncology.
What if vaginal estrogen is not enough?
Sometimes local treatment helps but does not fully solve the problem. Dr. Hirsch notes that some patients eventually need to discuss systemic hormone therapy when severe GSM symptoms do not respond sufficiently to local products.
That does not mean everyone with GSM needs systemic HRT. It means the treatment plan should follow the symptom pattern. Some women need local treatment only. Some need systemic treatment for hot flashes, sleep, or broader symptoms and local vaginal treatment for GSM. Some need in-person pelvic floor, urology, dermatology, or gynecology evaluation because pain has more than one driver.
How Flourish can help
Flourish provides clinician-reviewed perimenopause and menopause care. If your symptoms fit GSM and vaginal estrogen is clinically appropriate, Flourish can discuss options in the context of your symptoms, health history, medication preferences, and pharmacy access.
Flourish can also help you understand whether your symptoms are local, systemic, or both. If you are having hot flashes, night sweats, sleep disruption, mood changes, or brain fog along with vaginal or urinary symptoms, your plan may need to address more than one symptom pathway.
If medication is clinically appropriate, prescriptions can be sent to the pharmacy you choose. Flourish does not sell or ship medication, and it does not replace in-person pelvic exams, urgent care, STI evaluation, or urology/gynecology evaluation when those are needed.
What to ask before starting
Questions to ask
Make the vaginal estrogen conversation clearer
- Do my symptoms sound like GSM?
- Do I need an in-person exam first?
- Is vaginal estrogen appropriate for my medical history?
- Which form should I use and why?
- Do I need to apply it internally, externally, or both?
- How long should I use it before reassessing?
- What symptoms should prompt follow-up?
- If I am already on systemic HRT, do I still need local vaginal estrogen?
What to read next
For a broader GSM guide, read Vaginal Dryness, GSM, and Pain With Sex. For broader hormone therapy context, read Is HRT Right for Me?. If you want to understand prescription logistics, read How Menopause Prescriptions Work Online.